T. Ishitsu

发表

Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients

Y. Ando, K. Nakagawa, Shiro Nagata, 2008, The Journal of pharmacy and pharmacology.

ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.

H. Tan, P. Kwan, K. Lim, 2014, Pharmacogenomics.

Glutathione-S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes are risk factors for increased serum gamma-glutamyltransferase in valproic acid-treated patients.

K. Nakagawa, Takayuki Seo, T. Ishitsu, 2008, Clinica chimica acta; international journal of clinical chemistry.

Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity.

K. Nakagawa, M. Hori, Takayuki Seo, 2007, Pharmacogenomics.

Population Estimation of the Effects of Cytochrome P450 2C9 and 2C19 Polymorphisms on Phenobarbital Clearance in Japanese

K. Nakagawa, Naoyuki Nakada, Shuji Goto, 2007, Therapeutic drug monitoring.

Muscle fiber type transformation in nemaline myopathy and congenital fiber type disproportion

T. Miike, Y. Ohtani, T. Ishitsu, 1986, Brain and Development.

Cytochrome P450 2C19 polymorphisms and valproic acid‐induced weight gain

K. Oniki, A. Kajiwara, K. Nakagawa, 2016, Acta neurologica Scandinavica.

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy

K. Oniki, K. Nakagawa, J. Saruwatari, 2015, Neuropsychiatric disease and treatment.

A Possible Association of Sex Hormone-Binding Globulin with Weight Gain in the Valproic Acid-Treated Female Patients with Epilepsy

K. Oniki, A. Kajiwara, K. Nakagawa, 2014 .

Atrioventricular block and diastolic dysfunction in a patient with Sanfilippo C.

I. Misumi, T. Shimazu, K. Ebihara, 2010, Internal medicine.

Behavior of sarcotubular system formation in experimentally induced regeneration of muscle fibers

I. Nonaka, T. Miike, Y. Ohtani, 1984, Journal of the Neurological Sciences.

Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain α-keto acid dehydrogenase complex

H. Mitsubuchi, Y. Indo, I. Matsuda, 1998, Journal of Human Genetics.

Population Estimation Regarding the Effects of Cytochrome P450 2C19 and 3A5 Polymorphisms on Zonisamide Clearance

K. Nakagawa, Atsuko Wanibuchi, Takayuki Seo, 2008, Therapeutic drug monitoring.

Two siblings with microcephaly associated with calcification of cerebral white matter

I. Matsuda, T. Ishitsu, S. Chikazawa, 1985, Japanese Journal of Human Genetics.

Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy

K. Nakagawa, J. Saruwatari, T. Ishitsu, 2010, Pharmaceuticals.

Heterogeneous phenotypes of mitochondrial encephalomyopathy in a single kindred

A. Kitano, T. Miike, I. Matsuda, 1987, Neurology.

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis

K. Oniki, K. Nakagawa, J. Saruwatari, 2015, PloS one.

Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis

K. Oniki, J. Saruwatari, S. Kaneko, 2014, PloS one.

Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy.

K. Nakagawa, M. Hori, Takayuki Seo, 2008, Pharmacogenomics.

[Rud's syndrome].

T. Ishitsu, 1977, Nihon rinsho. Japanese journal of clinical medicine.

Anticonvulsant-induced rickets associated with renal tubular acidosis and normal level of serum 1,25-dihydroxyvitamin D.

I. Matsuda, Y. Seino, T. Ishitsu, 1981, American journal of diseases of children.

The clinical impact of cytochrome P450 polymorphisms on anti-epileptic drug therapy

K. Nakagawa, J. Saruwatari, S. Kaneko, 2010 .

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

K. Nakagawa, Naoyuki Nakada, Takayuki Seo, 2006, Pharmacogenomics.

Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.

K. Nakagawa, Tomohide Abe, M. Hori, 2008, British journal of clinical pharmacology.

Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy

K. Nakagawa, J. Saruwatari, S. Kaneko, 2014, Therapeutic drug monitoring.

An electron microscopical study of the T‐system in biopsied muscles from fukuyama type congenital muscular dystrophy

I. Nonaka, T. Miike, Y. Ohtani, 1984, Muscle & nerve.

AN ELECTRON MICROSCOPICAL STUDY OF THE TYPE CONGENITAL MUSCULAR DYSTROPHY T-SYSTEM IN BlOPSlED MUSCLES FROM FUKUYAMA

T. Miike, Y. Ohtani, T. Ishitsu, 2004 .

Pregnane X receptor and hepatocyte nuclear factor 4&agr; polymorphisms are cooperatively associated with carbamazepine autoinduction

K. Oniki, K. Nakagawa, J. Saruwatari, 2014, Pharmacogenetics and genomics.

Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases

K. Oniki, K. Nakagawa, J. Saruwatari, 2012, Epilepsy Research.

Familial Mitochondrial Encephalomyopathy with Stroke‐like Episodes and Episodic Disturbances of Consciousness: A Study of Pedigree Including Three Generations with Multisystemic Abnormalities

T. Miike, T. Miyakawa, S. Katsuragi, 1987, The Japanese journal of psychiatry and neurology.

ABCC2 haplotype is not associated with drug‐resistant epilepsy

T. Shuto, K. Oniki, K. Nakagawa, 2008, The Journal of pharmacy and pharmacology.

[Familial cases of mitochondrial cytopathy].

I. Matsuda, A. Kitano, T. Ishitsu, 1987, Rinshō shinkeigaku Clinical neurology.

Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy

K. Nakagawa, Naoyuki Nakada, Takayuki Seo, 2006, Clinical pharmacology and therapeutics.